South Lyon, MI, United States of America

Narendra D Lalwani




Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2005-2008

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Narendra D Lalwani

Introduction

Narendra D Lalwani is a notable inventor based in South Lyon, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of acute coronary syndromes. With a total of two patents to his name, his work has the potential to impact many lives.

Latest Patents

Lalwani's latest patents include innovative pharmaceutical formulations and methods for treating acute coronary syndromes. One of his inventions provides methods and formulations that utilize an Apolipoprotein A-I Milano:phospholipid complex to effectively reduce and stabilize atherosclerotic plaque. Additionally, he has developed methods and compositions for treating disorders using non-human animal Apolipoprotein A-I protein. This invention addresses various conditions associated with dyslipidemia, including hyperlipidemia, cardiovascular disease, and even viral infections.

Career Highlights

Throughout his career, Lalwani has worked with prominent companies such as Pfizer Corporation and Esperion Therapeutics, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Lalwani has collaborated with notable professionals in his field, including Charles Larry Bisgaier and Wendi Rodrigueza. These collaborations have likely enriched his research and development efforts.

Conclusion

Narendra D Lalwani's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes. His patents reflect a deep understanding of complex medical issues and a dedication to finding effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…